Discussion
The tripentone MR22388 has been identified as a potential anti-tumour agent and demonstrated strong
in vitro anti-proliferative and cytotoxic activities on various cell types
[
10,
15,
16]. We observed similar effects in two chemoresistant ovarian cancer cell lines. MR22388 exposure induced strong cell cycle perturbations and triggered apoptosis in a concentration dependent manner.
MR22388 has been shown to be able to exert various effects such as anti-tubulin effects
[
15] and inhibition of GSK3, CDK1
[
11] and showed an affinity for FLT3-ITD
[
10].
However, whatever are the MR22388 direct targets, we focused our attention on possible indirect effects of MR22388 on Bcl-2 family members since we previously demonstrated that anti-apoptotic proteins Bcl-x
L and Mcl-1 cooperate to protect ovarian carcinoma cells against apoptosis. Indeed, their concomitant inhibition leads to massive cell death, even in absence of chemotherapy
[
6,
7]. Here we showed that Mcl-1 protein (but not mRNA) was drastically decreased in both cell lines after exposure to MR22388.
Mcl-1 is submitted to a rapid turnover, and the control of its expression could involve both transcriptional and post-translational mechanisms. Its interactions with other Bcl-2 family members can favour its stabilization or its degradation, depending of the partner
[
17]. Mcl-1 degradation can involve the proteasome pathway following JNK and GSK3 associated Mcl-1 phosphorylations
[
18], but can also be a consequence of caspases activity
[
19]. This last possibility has been excluded in our model since Mcl-1 was decreased even in condition in which apoptosis is not detected (24 h).
We also detected the appearance of the ser62-phosphorylated form of Bcl-x
L. Phosphorylated forms have been previously described by others in response to various stresses
[
20,
21]. Ser62-phosphorylated form has been associated with a loss of anti-apoptotic function
[
22] and to the appearance of a capacity of phospho-Bcl-x
L to translocate in the nucleus to lead to a G2-M cell cycle arrest. Moreover, these events as well as Bcl-x
L ser62-phosphorylation have been related to the activation of JNK, among other kinases
[
23].
Interestingly, it has also been shown that phosphorylation of Mcl-1 by JNK (itself activated by various apoptotic stresses) is required for subsequent docking of GSK3 on Mcl-1 allowing Mcl-1 phosphorylation, ubiquitinylation and degradation
[
24].
Altogether, our observations (G2-M blockade, Mcl-1 expression decrease and phosphorylation of Bcl-xL on ser62) argue in favour of an activation of cell-death related signalling pathways such as JNK pathway by MR22388.
In any case, the capacity of MR22388 to inhibit Mcl-1 could be positively exploited in the context of Bcl-xL-targeting strategies. Here we showed that the association of MR22388 with ABT-737 was highly cytotoxic, in a manner correlated with the disappearance of Mcl-1.
Here we could hypothesize the existence of cooperation between tripentone that decrease Mcl-1 expression level and ABT-737 that inhibits Bcl-x
L and consequently releases the BH3-only protein Bim from Bcl-x
L. Bim subsequently becomes able to inactivate residual Mcl-1 protein, and to activate Bax/Bak apoptotic proteins. Indeed, a shuttling of Bim sequestration between Mcl-1 and Bcl-x
L, depending of their respective expression level has been recently described
[
25], Bcl-x
L being here presented as a determinant of the response to Mcl-1 inhibiting agents. In our model, MR22388 and ABT-737 should thus be considered as co-sensitizer agents.
In summary, although MR22388 activity is not yet fully understood, its interesting effect on the modulation of Bcl-2 family proteins could be positively exploited in the context of Bcl-xL-targeting strategies such as emerging BH3-mimetic molecules.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
JT carried out and coordinated experiments and results analysis, and participated to the construction of the manuscript. AMF participated in study design and FG carried out the western blot assays. EB carried out xCELLigence studies. MHL performed RT-qPCR assays. EA carried out cell culture and assisted xCELLIgence studies. SR coordinated all studies concerning MR22388. PG and LP conceived the study, participated in its design, drafted the manuscript and coordinated its writing. All authors read and approved the final manuscript.